Cathy Brewer

39.3k total citations
16 papers, 547 citations indexed

About

Cathy Brewer is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Cathy Brewer has authored 16 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Cathy Brewer's work include Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Cathy Brewer is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Cathy Brewer collaborates with scholars based in United States, Mexico and India. Cathy Brewer's co-authors include Gene H. Barnett, David M. Peereboom, Manmeet S. Ahluwalia, Michael A. Vogelbaum, Glen Stevens, John H. Suh, Robert J. Weil, Paul Elson, Steven A. Toms and Neeraj Agarwal and has published in prestigious journals such as Journal of Clinical Oncology, Journal of neurosurgery and Neurosurgery.

In The Last Decade

Cathy Brewer

16 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cathy Brewer United States	10	367	173	141	122	98	16	547
Edwin Lok United States	15	485 1.3×	186 1.1×	111 0.8×	135 1.1×	188 1.9×	30	783
Stevie Threatt United States	12	501 1.4×	169 1.0×	198 1.4×	84 0.7×	122 1.2×	37	664
Eduard B. Dinca United Kingdom	11	284 0.8×	97 0.6×	251 1.8×	109 0.9×	118 1.2×	17	658
Benedikte Hasselbalch Denmark	9	399 1.1×	136 0.8×	156 1.1×	60 0.5×	77 0.8×	22	491
Javier Gonzalez United States	7	401 1.1×	272 1.6×	144 1.0×	73 0.6×	103 1.1×	13	692
Richard Zuniga United States	6	360 1.0×	211 1.2×	121 0.9×	52 0.4×	85 0.9×	16	498
Emese Filka United States	6	533 1.5×	202 1.2×	240 1.7×	77 0.6×	105 1.1×	9	672
Christina Jackson United States	14	393 1.1×	103 0.6×	133 0.9×	76 0.6×	90 0.9×	29	708
Roy Torcuator United States	8	451 1.2×	233 1.3×	114 0.8×	54 0.4×	105 1.1×	8	585
Kirsten Grunnet Denmark	14	494 1.3×	179 1.0×	151 1.1×	56 0.5×	76 0.8×	25	588

Countries citing papers authored by Cathy Brewer

Since Specialization

Citations

This map shows the geographic impact of Cathy Brewer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Brewer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Brewer more than expected).

Fields of papers citing papers by Cathy Brewer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Brewer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Brewer. The network helps show where Cathy Brewer may publish in the future.

Co-authorship network of co-authors of Cathy Brewer

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Brewer. A scholar is included among the top collaborators of Cathy Brewer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Brewer. Cathy Brewer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Fallah, Jaleh, Rekha Chaudhary, Lisa R. Rogers, et al.. (2020). Clinical outcomes of the combination of bevacizumab and ttfields in patients with recurrent glioblastoma: Results of a phase II clinical trial.. Journal of Clinical Oncology. 38(15_suppl). 2537–2537. 14 indexed citations

Fallah, Jaleh, Rekha Chaudhary, Lisa R. Rogers, et al.. (2019). ACTR-26. SAFETY AND EFFICACY OF BEVACIZUMAB PLUS TTFIELDS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): DATA FROM A PHASE II CLINICAL TRIAL. Neuro-Oncology. 21(Supplement_6). vi18–vi18. 4 indexed citations

Vogelbaum, Michael A., Cathy Brewer, Gene H. Barnett, et al.. (2018). First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1. Journal of neurosurgery. 130(2). 1–10. 47 indexed citations

Peereboom, David M., Justin D. Lathia, Tyler Alban, et al.. (2017). Targeting myeloid derived suppressor cells: Phase 0/1 trial of low dose capecitabine + bevacizumab in patients with recurrent glioblastoma.. Journal of Clinical Oncology. 35(15_suppl). e13507–e13507. 1 indexed citations

Abbassy, Mahmoud, Symeon Missios, Gene H. Barnett, et al.. (2017). Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma. Neurosurgery. 83(3). 385–392. 21 indexed citations

Orchard, Guy, et al.. (2015). Development of new and accurate measurement devices (TruSlice and TruSlice Digital) for use in histological dissection: an attempt to improve specimen dissection precision. British Journal of Biomedical Science. 72(3). 140–145. 5 indexed citations

Ahluwalia, Manmeet S., Samuel T. Chao, Michael Parsons, et al.. (2015). Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1–3 newly diagnosed brain metastases. Journal of Neuro-Oncology. 124(3). 485–491. 17 indexed citations

Ahluwalia, Manmeet S., Hao Xie, Saurabh Dahiya, et al.. (2014). Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study. Journal of Neuro-Oncology. 122(1). 111–119. 14 indexed citations

Sloan, Andrew E., Manmeet S. Ahluwalia, Sunil Manjila, et al.. (2013). Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma. Journal of neurosurgery. 118(6). 1202–1219. 182 indexed citations

10.

Peereboom, David M., Samuel T. Chao, John H. Suh, et al.. (2012). Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery (SRS) in patients with 1-3 newly diagnosed brain metastases.. Journal of Clinical Oncology. 30(15_suppl). 2018–2018. 1 indexed citations

11.

Peereboom, David M., Dale R. Shepard, Manmeet S. Ahluwalia, et al.. (2009). Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. Journal of Neuro-Oncology. 98(1). 93–99. 144 indexed citations

12.

Altshuler, David, Mia Klannemark, Cecilia M. Lindgren, et al.. (2005). et Lander ES. 2000. The common PPARgamma Prol2Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet Sep; 26 (l): 76-80. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 2 indexed citations

13.

Brewer, Cathy, John H. Suh, Glen Stevens, et al.. (2005). Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly-diagnosed glioblastoma multiforme. Journal of Clinical Oncology. 23(16_suppl). 1567–1567. 14 indexed citations

14.

Vogelbaum, Michael A., David M. Peereboom, Glen Stevens, Gene H. Barnett, & Cathy Brewer. (2004). Phase II trial of the EGFR tyrosine kinase inhibitor erlotinib for single agent therapy of recurrent Glioblastoma Multiforme: Interim results. Journal of Clinical Oncology. 22(14_suppl). 1558–1558. 57 indexed citations

15.

Vogelbaum, Michael A., et al.. (2004). Phase II trial of the EGFR tyrosine kinase inhibitor erlotinib for single agent therapy of recurrent Glioblastoma Multiforme: Interim results. Journal of Clinical Oncology. 22(14_suppl). 1558–1558. 23 indexed citations

16.

Penny, Lucas, Rebecca N. Baergen, A A Larson, et al.. (1994). Sub-chromosomal localization of a putative tumor-suppressor gene involved in cervical cancers to 11q22–q24. Cancer Genetics and Cytogenetics. 77(2). 196–196. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact